Emerald Health Therapeutics, Inc.

Emerald Health Therapeutics, Inc. is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis and non-cannabis products, with an emphasis on life science-based innovation and production excellence. Emerald’s three distinct operating assets are designed to uniquely serve the Canadian marketplace and international opportunities.

Recent News

  • Emerald Health Therapeutics Establishes Partnership with Spanish Greenhouse Grower for GMP-Certified Cannabis

    Vancouver, British Columbia--(Newsfile Corp. - March 17, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has formed a partnership with Medical Plants SLU, based in Almeria, Spain, in which it will provide resources and expertise to assist Medical Plants to produce medical cannabis dried flower and 2.0 products to serve emerging legal medical cannabis markets in the EU and other countries that require high-grade GMP-certified flower or derivatives. Medical Plants is a wholly-owned subsidiary of Cualin...

    2021-03-17 7:00 AM EDT
  • Emerald Health Therapeutics Announces Intention to List on Canadian Securities Exchange

    Vancouver, British Columbia--(Newsfile Corp. - March 9, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it has applied to the Canadian Securities Exchange ("CSE") to have its common shares listed for trading on the CSE. In connection with the listing of its common shares on the CSE, Emerald will apply to the TSX Venture Exchange ("TSXV") to have its common shares delisted from trading on the TSXV.Listing its common shares on the CSE will...

    2021-03-09 7:00 AM EST
  • Emerald Health Therapeutics to Close Greater Vancouver Production Facility

    Vancouver, British Columbia--(Newsfile Corp. - February 18, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it will cease operations at its cannabis production facility in Greater Vancouver, British Columbia effective March 31, 2021 and will consider strategic alternatives for this facility. "Closing our Greater Vancouver production facility is part of Emerald's revised business strategy and transition away from the value segment of the cannabis market toward science-driven product development and the defined-scale production of...

    2021-02-18 4:45 PM EST
  • Emerald Health Therapeutics Receives $20.5M Payment from Village Farms and Outlines Growth Plans

    Vancouver, British Columbia--(Newsfile Corp. - February 9, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has received from Village Farms International Inc. $19.9M plus $621,534.25 in interest, representing full repayment of the promissory note issued by Village Farms to Emerald as part of its purchase of Emerald's interest in the Pure Sunfarms joint venture which closed in November 2020. This was the final payment due as part of this transaction. "After previously eliminating all third-party debt, and...

    2021-02-09 7:00 AM EST
  • Emerald Health Therapeutics Promotes Two Executives to Senior Roles

    Vancouver, British Columbia--(Newsfile Corp. - February 5, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has promoted Orville Bovenschen to the position of Senior Vice President, Operations and Rebecca Wong to Senior Vice President, Quality & Regulatory Affairs.Mr. Bovenschen has over 16 years of progressive experience in financial management, project and operations management, and strategy development and operational planning, including risk management. With Emerald since 2017, he has overseen the planning and management of all...

    2021-02-05 7:00 AM EST
  • Emerald Health Therapeutics Settles Outstanding Amounts

    Vancouver, British Columbia--(Newsfile Corp. - January 13, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it has settled all outstanding amounts owing to the original vendors (the "Vendors") in connection with Emerald's 2018 acquisition of Verdélite Sciences, Inc. ("Verdélite Sciences") and Verdélite Property Holdings, Inc. ("Verdélite Property" and, together with Verdélite Sciences, the "Subsidiaries").The Subsidiaries were purchased by Emerald from the Vendors in 2018 and a portion of the purchase price payable to the...

    2021-01-13 7:00 AM EST
  • Emerald Health Therapeutics' Partner STENOCARE Makes First Delivery of Medical Cannabis Oil to Swedish Patients

    Vancouver, British Columbia--(Newsfile Corp. - December 29, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") today announced that its partner, STENOCARE A/S, completed its first shipment and delivery of Emerald medical cannabis oil to patients in Sweden. In Sweden, several patients diagnosed with chronic nervous system pain, spasms and nausea from chemotherapy have via their doctor previously applied for a prescription for treatment with medical cannabis oil. Emerald and STENOCARE announced on September 8th approval from the...

    2020-12-29 7:00 AM EST
  • Emerald Health Therapeutics Introduces High Potency SYNC(TM) 100 CBD Oil

    Vancouver, British Columbia--(Newsfile Corp. - December 17, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has launched and made its first shipment of its new SYNC™ 100 CBD oil to the province of Saskatchewan. Shipments to Alberta and BC are scheduled for next week, with product expected to be available for purchase online and in licensed stores before the new year.This natural flavoured whole-flower cannabis oil is made with all-natural ingredients and vegan, 100%-organic, palm-free coconut oil....

    2020-12-17 7:00 AM EST